Question 1

Who are the top researchers at Vaxxas (Australia)?

Accepted Answer

Ranked on the quality score, Angus Harry Forster and Ben Baker lead among researchers whose main affiliation is Vaxxas (Australia).

Question 2

What are the most cited papers from Vaxxas (Australia)?

Accepted Answer

The most cited paper from Vaxxas (Australia) is "Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)" (Germain J. P. Fernando, Julian Hickling, Cesar M. Jayashi Flores et al., 2018), with 129 citations. Next come "Dissolvable polymer microneedles for drug delivery and diagnostics" (127) and "Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial" (102).

Question 3

Which research topics does Vaxxas (Australia) publish most on?

Accepted Answer

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, Animal Virus Infections Studies and Immunotherapy and Immune Responses.

Question 4

Which fields of science does Vaxxas (Australia) work in?

Accepted Answer

In all years, 53% of research at Vaxxas (Australia) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (40%), Immunology and Microbiology (17%), Pharmacology, Toxicology and Pharmaceutics (15%). It does 1.8× the world's share of Life Sciences.

Question 5

Is Vaxxas (Australia)'s research output growing?

Accepted Answer

Output in 2022-2025 was 67% higher than in 2018-2021.